Corbus Pharmaceuticals Holdings Inc (LTS:0SZI)
$ 18.62 0.0962 (0.52%) Market Cap: 230.64 Mil Enterprise Value: 98.41 Mil PE Ratio: 0 PB Ratio: 1.68 GF Score: 37/100

Q4 2019 Corbus Pharmaceuticals Holdings Inc Earnings Call Transcript

Mar 12, 2020 / 12:30PM GMT
Release Date Price: $197.69
Operator

Good morning, and welcome to the Corbus Pharmaceuticals Fourth Quarter and Year-End December 31, 2019 Earnings Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.

It is now my pleasure to introduce your host, Ted Jenkins, Senior Director, Investor Relations and Corporate Communications. Please go ahead, sir.

Ted Jenkins
Corbus Pharmaceuticals Holdings, Inc. - Senior Director of IR & Communications

Thank you. Good morning, everyone.

At this time, I'd like to remind our listeners that remarks made during this call may state management's intentions, hopes, beliefs, expectations or projections of the future. These are forward-looking statements that involve risks and uncertainties. Forward-looking statements on this call are made pursuant to the safe harbor provisions of the federal securities laws. These forward-looking statements are based on Corbus' current expectations and actual results could differ materially. As a result, you should not place undue reliance on any forward-looking statements.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investorsā€™ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot